BioSpecifics Technologies Corp. - Home

Time 2021-01-08 11:04:41

Web Name: BioSpecifics Technologies Corp. - Home

WebSite: http://www.biospecifics.com

ID:160556

Keywords:

Technologies,BioSpecifics,Home,

Description:

Building a next-generation company upon the foundation of our collagenase-based therapies About BioSpecificsBioSpecifics is a biopharmaceutical company that originated and continues to develop collagenase-based therapies. Collagenases are naturally occurring enzymes responsible for the breakdown of collagen. Collagen is the main structural protein in the extracellular matrix in the various connective tissues of the body and is the most abundant protein in mammals. Local accumulations of excess collagen are associated with a number of medical conditions. We have developed a first-in-class collagenase-based product collagenase clostridium histolyticum (CCH) marketed in the U.S. as XIAFLEX® by our partner Endo Pharmaceuticals for the treatment of Dupuytren's contracture and Peyronie's disease.In addition to investing in the development of several potential new indications for its collagenase-based technology, BioSpecifics is seeking to partner with companies that possess novel therapeutics that will deliver meaningful benefits for patients. Pipeline The XIAFLEX® research and development pipeline includes several additional potential indications including adhesive capsulitis and plantar fibromatosis Learn More To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.At BIOSPECIFICS, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.By providing your email address below, you are providing consent to BIOSPECIFICS to send you the requested Investor Email Alert updates.* Required

TAGS:Technologies BioSpecifics Home 

<<< Thank you for your visit >>>

Hot Websites